MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,210,996 | +3.4% | 119,628 | -14.2% | 0.00% | 0.0% |
| Q2 2023 | $5,040,171 | +89.2% | 139,501 | +94.7% | 0.00% | +100.0% |
| Q1 2023 | $2,663,687 | +87.4% | 71,643 | +128.4% | 0.00% | 0.0% |
| Q4 2022 | $1,421,284 | -35.2% | 31,368 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,192,000 | -13.2% | 31,381 | -16.5% | 0.00% | 0.0% |
| Q2 2022 | $2,524,000 | -13.8% | 37,600 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $2,927,000 | -64.5% | 35,594 | -36.7% | 0.00% | -66.7% |
| Q4 2021 | $8,251,000 | -2.3% | 56,245 | +17.8% | 0.00% | 0.0% |
| Q3 2021 | $8,447,000 | +34.3% | 47,749 | +22.6% | 0.00% | 0.0% |
| Q2 2021 | $6,290,000 | -53.1% | 38,941 | -50.3% | 0.00% | -50.0% |
| Q1 2021 | $13,412,000 | -22.4% | 78,298 | -0.5% | 0.01% | -25.0% |
| Q4 2020 | $17,285,000 | +40.8% | 78,698 | +6.4% | 0.01% | +14.3% |
| Q3 2020 | $12,276,000 | +31.3% | 73,931 | -9.8% | 0.01% | +40.0% |
| Q2 2020 | $9,353,000 | +98.1% | 81,923 | +33.4% | 0.01% | +66.7% |
| Q1 2020 | $4,722,000 | -38.0% | 61,423 | +3.9% | 0.00% | -25.0% |
| Q4 2019 | $7,619,000 | +68.3% | 59,123 | +1.7% | 0.00% | +33.3% |
| Q3 2019 | $4,528,000 | -24.4% | 58,123 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $5,987,000 | +131.4% | 58,123 | +64.7% | 0.00% | +100.0% |
| Q1 2019 | $2,587,000 | -41.9% | 35,289 | -66.4% | 0.00% | -33.3% |
| Q4 2018 | $4,450,000 | +216.1% | 104,900 | +250.8% | 0.00% | +200.0% |
| Q3 2018 | $1,408,000 | -2.8% | 29,900 | +1.7% | 0.00% | 0.0% |
| Q2 2018 | $1,449,000 | +1205.4% | 29,400 | +38.0% | 0.00% | – |
| Q1 2017 | $111,000 | +1.8% | 21,300 | -7.0% | 0.00% | – |
| Q4 2016 | $109,000 | -27.8% | 22,900 | 0.0% | 0.00% | – |
| Q3 2016 | $151,000 | +20.8% | 22,900 | 0.0% | 0.00% | – |
| Q2 2016 | $125,000 | -46.6% | 22,900 | +209.5% | 0.00% | – |
| Q4 2015 | $234,000 | -8.2% | 7,400 | 0.0% | 0.00% | – |
| Q3 2015 | $255,000 | +479.5% | 7,400 | +393.3% | 0.00% | – |
| Q1 2015 | $44,000 | +528.6% | 1,500 | +275.0% | 0.00% | – |
| Q4 2014 | $7,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | -56.2% | 400 | -50.0% | 0.00% | – |
| Q2 2014 | $16,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |